LIM, Megan S, Michelle FOLEY, Lara MUSSOLIN, Reiner SIEBERT and Suzanne Dawn TURNER. Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. OXFORD: ELSEVIER SCI LTD, 2023, vol. 36, No 1, p. 1-10. ISSN 1521-6926. Available from: https://dx.doi.org/10.1016/j.beha.2023.101447.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma
Authors LIM, Megan S, Michelle FOLEY, Lara MUSSOLIN, Reiner SIEBERT and Suzanne Dawn TURNER (826 United Kingdom of Great Britain and Northern Ireland, guarantor, belonging to the institution).
Edition BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, OXFORD, ELSEVIER SCI LTD, 2023, 1521-6926.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.100 in 2022
RIV identification code RIV/00216224:14740/23:00133503
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.beha.2023.101447
UT WoS 000974139900001
Keywords in English Pathobiology; Genetic; Childhood; Adolescent and young adult; Non -Hodgkin lymphoma
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 5/4/2024 10:49.
Abstract
Mature non-Hodgkin lymphomas (NHL) in the childhood, adolescent and young adult (CAYA) population are rare and exhibit unique clinical, immunophenotypic and genetic characteristics. Application of large-scale unbiased genomic and proteomic technologies such as gene expression profiling and next generation sequencing (NGS) have led to enhanced understanding of the genetic basis for many lymphomas in adults. However, studies to investigate the pathogenetic events in CAYA population are relatively sparse. Enhanced understanding of the pathobiologic mechanisms involved in non-Hodgkin lymphomas in this unique population will allow for improved recognition of these rare lymphomas. Elucidation of the pathobiologic differences between CAYA and adult lymphomas will also lead to the design of more rational and much needed, less toxic therapies for this population. In this review, we summarize recent insights gained from the proceedings of the recent 7th International CAYA NHL Symposium held in New York City, New York October 20-23, 2022.
PrintDisplayed: 17/7/2024 03:55